At a glance
- Originator Merck & Co
- Class Antithrombotics
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 11 Oct 1999 New profile
- 11 Oct 1999 Preclinical development for Thrombosis in USA (Unknown route)